联系客服

300981 深市 中红医疗


首页 公告 中红医疗:2022年度财务决算报告

中红医疗:2022年度财务决算报告

公告日期:2023-04-25

中红医疗:2022年度财务决算报告 PDF查看PDF原文

              中红普林医疗用品股份有限公司

                  2022 年度财务决算报告

        2022 年,中红普林医疗用品股份有限公司(以下简称“公司”)财务部门严

    格按照《企业会计准则》《企业会计制度》《会计法》的规定进行财务核算,公

    司所编制的年度报表经容诚会计师事务所(特殊普通合伙)审计,现将 2022 年

    度财务决算情况报告如下:

        一、主要财务数据

                                          2021 年            本年比上年            2020 年

                    2022 年                                      增减

                                  调整前        调整后        调整后        调整前        调整后

营业收入(元)    1,572,568,5  4,909,310,9  4,909,310,936      -67.97%  4,778,406,87  4,778,406,872
                        13.46        36.58            .58                        2.04            .04

归属于上市公司股  66,916,009.  2,341,903,8  2,341,903,879      -97.14%  2,663,518,71  2,663,518,716
东的净利润(元)            08        79.36            .36                        6.36            .36

归属于上市公司股            -  2,245,883,9  2,245,883,902                2,648,179,47  2,648,179,477
东的扣除非经常性  69,820,974.        02.64            .64    -103.11%          7.94            .94
损益的净利润(元)          44

经营活动产生的现  106,707,621  2,362,497,6  2,362,497,606      -95.48%  2,719,677,05  2,719,677,059
金流量净额(元)          .94        06.63            .63                        9.06            .06

基本每股收益(元/          0.22        15.33          8.52      -97.42%        21.31          11.84
股)

稀释每股收益(元/          0.22        15.33          8.52      -97.42%        21.31          11.84
股)

加权平均净资产收        1.06%        46.92%        46.92%      -45.86%      168.97%        168.97%
益率

        二、财务状况及变动原因分析

        截止本报告期末,公司资产总额为 6,816,635,272.66 元,较年初下降 4.69%,

    公司负债总计为 684,053,845.41 元,较年初上升 14.47%。

                                                                            单位:元

                项目            2022 年 12 月 31 日  2022 年 1 月 1 日    同比变动

      货币资金                      484,763,831.34    844,386,723.59      -42.59%

      交易性金融资产              2,542,130,282.10  3,564,620,264.59      -28.68%

      应收票据                        8,862,368.59

      应收账款                      258,845,851.89    232,456,059.39        11.35%


应收款项融资                    1,397,672.59

预付款项                      20,429,661.47    22,995,469.86      -11.16%

其他应收款                    36,528,060.57    33,450,055.78        9.20%

存货                          421,648,279.72    463,605,442.57        -9.05%

持有待售资产                              0        42,442.48      -100.00%

其他流动资产                  673,362,656.44    43,737,663.09      1439.55%

债权投资                      115,539,971.48

其他权益工具投资              90,985,744.00    50,633,788.41        79.69%

其他非流动金融资产            84,000,000.00

固定资产                    1,638,535,198.55  1,494,957,162.28        9.60%

在建工程                      62,792,957.12    146,066,962.75      -57.01%

使用权资产                    13,441,800.09    16,977,679.11      -20.83%

无形资产                      148,848,140.05    66,013,829.21      125.48%

长期待摊费用                    1,703,818.94        72,658.44      2244.97%

递延所得税资产                42,988,970.47    21,831,319.53        96.91%

其他非流动资产                169,830,007.25    149,873,504.04        13.32%

资产总计                    6,816,635,272.66  7,151,721,025.12        -4.69%

短期借款                      50,042,206.51

交易性金融负债                    259,400.00

应付票据                      121,898,913.96    43,440,019.30      180.61%

应付账款                      269,938,952.32    341,801,628.06      -21.02%

合同负债                      70,406,527.61    110,018,059.77      -36.00%

应付职工薪酬                  47,393,351.37    49,087,962.37        -3.45%

应交税费                        7,636,806.54    11,011,000.57      -30.64%

其他应付款                    60,875,353.82      5,757,868.89      957.25%

一年内到期的非流动负债          6,965,293.24      3,469,143.61      100.78%

其他流动负债                    8,757,933.22        449,082.36      1850.18%

租赁负债                      10,125,710.80    13,713,458.19      -26.16%

长期应付款                      3,676,415.09

递延收益                      20,555,425.48      6,898,188.11      197.98%

递延所得税负债                  5,521,555.45    11,913,417.01      -53.65%

负债合计                      684,053,845.41    597,559,828.24        14.47%

股本                          300,006,000.00    166,670,000.00        80.00%

资本公积                    1,805,845,546.94  1,939,181,546.94        -6.88%

其他综合收益                    8,891,103.80    10,580,649.22      -15.97%

盈余公积                      95,661,783.43    83,335,000.00        14.79%

未分配利润                  3,908,973,226.37  4,354,394,000.72      -10.23%

归属于母公司所有者权益合计  6,119,377,660.54  6,554,161,196.88        -6.63%

少数股东权益                  13,203,766.71


 所有者权益合计              6,132,581,427.25  6,554,161,196.88        -6.43%

 负债和所有者权益总计        6,816,635,272.66  7,151,721,025.12        -4.69%

(1) 货币资金较年初减少 42.59%,主要系本期现金分红所致。
(2) 其他流动资产较年初上升 1439.55%,主要系定期存款及应计利息所致。(3) 其他权益工具投资较年初增加 79.69%,系本年度增加基金投资所致。
(4) 在建工程较年初减少 57.01%,系本年度新生产线建设完毕转入固定资产
    所致。
(5) 无形资产较年初增加 125.48%,主要系非同一控制下企业合并科伦医械所
    致。
[点击查看PDF原文]